Results 201 to 210 of about 51,530 (306)

Diagnosis and Treatments of Autoimmune Encephalitis

, 2013
Makoto Yoneda
openalex   +2 more sources

The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis [PDF]

, 2017
Silvy Mardiguian, Emma Ladds, Roberta Turner, Hazel Shepherd, Sandra J. Campbell, Daniel C. Anthony   +5 more
openalex   +1 more source

Pathogenic variants in chromatin‐related genes: Linking immune dysregulation to neuroregression and acute neuropsychiatric disorders

Developmental Medicine &Child Neurology, Volume 67, Issue 8, Page 1095-1102, August 2025.
Chromatin machinery influences how DNA is ‘wrapped’ around histones in the nucleosome of immune and brain cells. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16299 This original article is commented by Thompson on pages 975–976 of this issue. Abstract We report eight children with de novo pathogenic DNA variants in chromatin‐
Russell C. Dale, Shekeeb Mohammad, Velda X. Han, Hiroya Nishida, Himanshu Goel, Stuart G. Tangye, Georgina Hollway, Esther Tantsis, Deepak Gill, Shrujna Patel, Chromatin Immune‐Brain Group, Michael Lonergan, Melanie Wong, Kavitha Kothur, Erica Tsang   +14 more
wiley   +1 more source

Autoimmune encephalitis-associated epilepsy. [PDF]

Nat Rev Neurol
Steriade C, Bauer J, Bien CG.
europepmc   +1 more source

Approach and overview of autoimmune encephalitis: A review. [PDF]

Medicine (Baltimore)
Yucel Y, Sidow NO, Yilmaz A.
europepmc   +1 more source

Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia [PDF]

, 2017
Kristina R. Patterson, Josep Dalmau, Eric Lancaster   +2 more
openalex   +1 more source

Immune Checkpoint Inhibitor‐Related Dysautonomia in Merkel Cell Carcinoma: A Case Report

Cancer Reports, Volume 8, Issue 7, July 2025.
ABSTRACT Background Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block inhibitory pathways that cancer cells exploit to suppress T‐cell activation. Although immune‐related adverse events (irAEs) linked to ICI therapy are well documented and encompass dermatologic, endocrine, gastrointestinal, hepatic, and neurologic systems, ICI ...
Nidhi Kuchimanchi, Sai Gajula, Elizabeth M. Gaughan, Russell G. Witt   +3 more
wiley   +1 more source

Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort Study. [PDF]

Neurol Neuroimmunol Neuroinflamm
Bohn A, Angstwurm K, Bien CG, Doppler K, Ehmke L, Havla J, Hoffmann F, Hudasch D, Klausewitz J, Konen FF, Korporal-Kuhnke M, Kraft A, Kümpfel T, Leypoldt F, Madlener M, Pfeffer LK, Pfeuffer S, Pul D, Rada A, Rauer S, Sänger C, Seifert-Held T, Sühs KW, Thaler FS, Tsaktanis T, Vlad B, Wandinger KP, Wickel J, Tauber SC, GENERATE study group.   +29 more
europepmc   +1 more source

Autoantibodies against TRIM46 identified in a dog suffering from suspected meningoencephalomyelitis of unknown origin

Journal of Small Animal Practice, EarlyView.
P. L. Heidemann, A. C. Nilsson, S. G. Schmidt, E. Lattwein, C. Allberg, M. Blaabjerg, H. Gredal   +6 more
wiley   +1 more source

Primary Immunodeficiency Registry System: The Minimum Data Set Designing Phase—A Systematic Review and Quantitative Delphi Study

Health Science Reports, Volume 8, Issue 7, July 2025.
ABSTRACT Background and Aims Registries are powerful tools for data management. Designing a minimum data set as the first step in registry development helps collect relevant and efficient data. The aim of this study was to develop a minimum data set for the primary immunodeficiency registry system.
Saman Mohammadpour, Hassan Emami, Sima Shokri, Rafat Bagherzadeh, Soqrat Omari Shekaftik, Zanko Hosseini   +5 more
wiley   +1 more source